Growth Metrics

Resmed (RMD) Equity Ratio (2016 - 2025)

Resmed's Equity Ratio history spans 16 years, with the latest figure at 0.74 for Q4 2025.

  • For Q4 2025, Equity Ratio rose 1.05% year-over-year to 0.74; the TTM value through Dec 2025 reached 0.74, up 1.05%, while the annual FY2025 figure was 0.73, 3.15% up from the prior year.
  • Equity Ratio reached 0.74 in Q4 2025 per RMD's latest filing, up from 0.74 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.74 in Q4 2025 to a low of 0.56 in Q4 2022.
  • Average Equity Ratio over 5 years is 0.67, with a median of 0.66 recorded in 2022.
  • Peak YoY movement for Equity Ratio: rose 18.1% in 2021, then decreased 15.73% in 2022.
  • A 5-year view of Equity Ratio shows it stood at 0.66 in 2021, then decreased by 15.73% to 0.56 in 2022, then increased by 15.92% to 0.65 in 2023, then rose by 13.33% to 0.74 in 2024, then rose by 1.05% to 0.74 in 2025.
  • Per Business Quant, the three most recent readings for RMD's Equity Ratio are 0.74 (Q4 2025), 0.74 (Q3 2025), and 0.73 (Q2 2025).